← Back to patent-cliff list
CAS 912444-71-4
benzyl 2-((2-amino-3-carbamoylphenyl)carbamoyl)-2-methylpyrrolidine-1-carboxylate
Codes: VELI-005
Application context (from source-drug indications)
GlioblastomaVeliparib Hydrochloride神经胶质肉瘤Veliparib HydrochlorideMetastatic breast cancerVeliparib HydrochlorideGliomaVeliparib Hydrochloride星形细胞瘤Veliparib HydrochlorideMyelofibrosisVeliparib Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Veliparib Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-benzyl 2-methyl pyrrolidine-1,2-dicarboxylate→1-benzyl 2-methyl 2-methylpyrrolidine-1,2-dicarboxylate→1-((benzyloxy)carbonyl)-2-methylpyrrolidine-2-carboxylic acid→2,3-diaminobenzamide→benzyl 2-((2-amino-3-carbamoylphenyl)carbamoyl)-2-methylpyrrolidine-1-carboxylate→(R)-benzyl 2-(4-carbamoyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidine-1-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.